{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:07:11Z","timestamp":1794938831201,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vitamin D deficiency has long been associated with reduced immune function that can lead to viral infection. Several studies have shown that Vitamin D deficiency is associated with increases the risk of infection with COVID-19. However, it is unknown if treatment with Vitamin D can reduce the associated risk of COVID-19 infection, which is the focus of this study. In the population of US veterans, we show that Vitamin D<jats:sub>2<\/jats:sub>and D<jats:sub>3<\/jats:sub>fills were associated with reductions in COVID-19 infection of 28% and 20%, respectively [(D<jats:sub>3<\/jats:sub>Hazard Ratio (HR)\u2009=\u20090.80, [95% CI 0.77, 0.83]), D<jats:sub>2<\/jats:sub>HR\u2009=\u20090.72, [95% CI 0.65, 0.79]]. Mortality within 30-days of COVID-19 infection was similarly 33% lower with Vitamin D<jats:sub>3<\/jats:sub>and 25% lower with D<jats:sub>2<\/jats:sub>(D<jats:sub>3<\/jats:sub>HR\u2009=\u20090.67, [95% CI 0.59, 0.75]; D<jats:sub>2<\/jats:sub>HR\u2009=\u20090.75, [95% CI 0.55, 1.04]). We also find that after controlling for vitamin D blood levels, veterans receiving higher dosages of Vitamin D obtained greater benefits from supplementation than veterans receiving lower dosages. Veterans with Vitamin D blood levels between 0 and 19\u00a0ng\/ml exhibited the largest decrease in COVID-19 infection following supplementation. Black veterans received greater associated COVID-19 risk reductions with supplementation than White veterans. As a safe, widely available, and affordable treatment, Vitamin D may help to reduce the severity of the COVID-19 pandemic.<\/jats:p>","DOI":"10.1038\/s41598-022-24053-4","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T13:29:40Z","timestamp":1668259780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Association between vitamin D supplementation and COVID-19 infection and mortality"],"prefix":"10.1038","volume":"12","author":[{"given":"Jason B.","family":"Gibbons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia C.","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"issue":"1","key":"24053_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nutres.2010.12.001","volume":"31","author":"KY Forrest","year":"2011","unstructured":"Forrest, K. Y. & Stuhldreher, W. L. Prevalence and correlates of vitamin D deficiency in US adults. Nutr. Res. 31(1), 48\u201354. https:\/\/doi.org\/10.1016\/j.nutres.2010.12.001 (2011).","journal-title":"Nutr. Res."},{"issue":"9","key":"24053_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.19722","volume":"3","author":"DO Meltzer","year":"2020","unstructured":"Meltzer, D. O. et al. Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Netw. Open. 3(9), e2019722. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.19722 (2020).","journal-title":"JAMA Netw. Open."},{"issue":"9","key":"24053_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239799","volume":"15","author":"Z Maghbooli","year":"2020","unstructured":"Maghbooli, Z. et al. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng\/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS ONE 15(9), e0239799. https:\/\/doi.org\/10.1371\/journal.pone.0239799 (2020).","journal-title":"PLoS ONE"},{"issue":"9","key":"24053_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239252","volume":"15","author":"HW Kaufman","year":"2020","unstructured":"Kaufman, H. W., Niles, J. K., Kroll, M. H., Bi, C. & Holick, M. F. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS ONE 15(9), e0239252. https:\/\/doi.org\/10.1371\/journal.pone.0239252 (2020).","journal-title":"PLoS ONE"},{"issue":"17","key":"24053_CR5","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1111\/febs.15495","volume":"287","author":"E Merzon","year":"2020","unstructured":"Merzon, E. et al. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: An Israeli population-based study. FEBS J. 287(17), 3693\u20133702. https:\/\/doi.org\/10.1111\/febs.15495 (2020).","journal-title":"FEBS J."},{"key":"24053_CR6","doi-asserted-by":"publisher","unstructured":"Israel, A., Assi Cicurel, A. A., Feldhamer, I., Dror, Y., Giveon, S. M., Gillis, D., Strich, D., & Lavie, G. The link between vitamin D deficiency and COVID-19 in a large population. medRxiv. Published online September 07, 2021. https:\/\/doi.org\/10.1101\/2020.09.04.20188268","DOI":"10.1101\/2020.09.04.20188268"},{"key":"24053_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.660420","volume":"8","author":"MR Akbar","year":"2021","unstructured":"Akbar, M. R., Wibowo, A., Pranata, R. & Setiabudiawan, B. Low serum 25-hydroxyvitamin D (Vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: A systematic review and meta-analysis. Front. Nutr. 8, 660420 (2021).","journal-title":"Front. Nutr."},{"key":"24053_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.663187","volume":"12","author":"G Sinkovits","year":"2021","unstructured":"Sinkovits, G. et al. Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection. Front. Immunol. 12, 663187 (2021).","journal-title":"Front. Immunol."},{"key":"24053_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463\u2013469 (2020).","journal-title":"Nature"},{"key":"24053_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-immunol-042617-053245","volume":"36","author":"EE West","year":"2018","unstructured":"West, E. E., Kolev, M. & Kemper, C. Complement and the regulation of T cell responses. Annu. Rev. Immunol. 36, 309\u2013338 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"24053_CR11","doi-asserted-by":"publisher","first-page":"eaay5731","DOI":"10.1126\/science.aay5731","volume":"371","author":"TJ Break","year":"2021","unstructured":"Break, T. J. et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science 371, eaay5731 (2021).","journal-title":"Science"},{"key":"24053_CR12","doi-asserted-by":"publisher","first-page":"eabg0833","DOI":"10.1126\/sciimmunol.abg0833","volume":"6","author":"B Yan","year":"2021","unstructured":"Yan, B. et al. SARS-CoV-2 drives JAK1\/2-dependent local complement hyperactivation. Sci. Immunol. 6, eabg0833 (2021).","journal-title":"Sci. Immunol."},{"key":"24053_CR13","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/ni.1917","volume":"11","author":"J Cardone","year":"2010","unstructured":"Cardone, J. et al. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 11, 862\u2013871 (2010).","journal-title":"Nat. Immunol."},{"key":"24053_CR14","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4049\/jimmunol.157.2.798","volume":"157","author":"RT Gazzinelli","year":"1996","unstructured":"Gazzinelli, R. T. et al. In the absence of endogenous IL10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accomplished by overproduction of IL12, IFN gamma and TNF alpha. J. Immunol. 157, 798\u2013805 (1996).","journal-title":"J. Immunol."},{"key":"24053_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01080-3","author":"D Chauss","year":"2021","unstructured":"Chauss, D. et al. Autocrine Vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Nat. Immunol. https:\/\/doi.org\/10.1038\/s41590-021-01080-3 (2021).","journal-title":"Nat. Immunol."},{"key":"24053_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6583","volume":"356","author":"AR Martineau","year":"2017","unstructured":"Martineau, A. R. et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 356, i6583. https:\/\/doi.org\/10.1136\/bmj.i6583 (2017).","journal-title":"BMJ"},{"key":"24053_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105751","volume":"203","author":"M Entrenas Castillo","year":"2020","unstructured":"Entrenas Castillo, M. et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J. Steroid Biochem. Mol. Biol. 203, 105751. https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105751 (2020).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"24053_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.26848","author":"IH Murai","year":"2021","unstructured":"Murai, I. H. et al. Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: A randomized clinical trial. JAMA https:\/\/doi.org\/10.1001\/jama.2020.26848 (2021).","journal-title":"JAMA"},{"key":"24053_CR19","unstructured":"Meltzer, D.O., Best, T., Schram, A., Solway, J. Comment on Murai, I.H., Fernandes, A.L., Sales, L.P., et al. Reanalysis suggests vitamin D decreased intensive care and mechanical ventilation use. JAMA (2021). Accessed March 21, 2021. Available at https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2776738."},{"key":"24053_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.736665","volume":"9","author":"I Chiodini","year":"2021","unstructured":"Chiodini, I. et al. Vitamin D status and SARS-CoV-2 infection and COVID-19 clinical outcomes. Front. Public Health. 9, 736665. https:\/\/doi.org\/10.3389\/fpubh.2021.736665 (2021).","journal-title":"Front. Public Health."},{"key":"24053_CR21","doi-asserted-by":"publisher","first-page":"23380","DOI":"10.1038\/s41598-021-02701-5","volume":"11","author":"C Loucera","year":"2021","unstructured":"Loucera, C. et al. Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients. Sci. Rep. 11, 23380. https:\/\/doi.org\/10.1038\/s41598-021-02701-5 (2021).","journal-title":"Sci. Rep."},{"issue":"2","key":"24053_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263069","volume":"17","author":"AA Dror","year":"2022","unstructured":"Dror, A. A. et al. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness. PLoS ONE 17(2), e0263069. https:\/\/doi.org\/10.1371\/journal.pone.0263069 (2022).","journal-title":"PLoS ONE"},{"key":"24053_CR23","doi-asserted-by":"publisher","first-page":"CD015043","DOI":"10.1002\/14651858.CD015043","volume":"5","author":"JK Stroehlein","year":"2021","unstructured":"Stroehlein, J. K. et al. Vitamin D supplementation for the treatment of COVID-19: A living systematic review. Cochrane Database Syst. Rev. 5, CD015043. https:\/\/doi.org\/10.1002\/14651858.CD015043 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"24053_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043737","volume":"11","author":"A Grove","year":"2021","unstructured":"Grove, A. et al. Association between vitamin D supplementation or serum vitamin D level and susceptibility to SARS-CoV-2 infection or COVID-19 including clinical course, morbidity and mortality outcomes? A systematic review. BMJ Open 11, e043737. https:\/\/doi.org\/10.1136\/bmjopen-2020-043737 (2021).","journal-title":"BMJ Open"},{"key":"24053_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12937-021-00744-y","volume":"20","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: A meta-analysis and GRADE assessment of cohort studies and RCTs. Nutr. J. 20, 89. https:\/\/doi.org\/10.1186\/s12937-021-00744-y (2021).","journal-title":"Nutr. J."},{"key":"24053_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-020-00398-z","author":"VM Mart\u00edn Gim\u00e9nez","year":"2020","unstructured":"Mart\u00edn Gim\u00e9nez, V. M. et al. Vitamin D deficiency in African Americans is associated with a high risk of severe disease and mortality by SARS-CoV-2. J. Hum. Hypertens. https:\/\/doi.org\/10.1038\/s41371-020-00398-z (2020).","journal-title":"J. Hum. Hypertens."},{"issue":"2","key":"24053_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000458765","volume":"70","author":"DK Sanghera","year":"2017","unstructured":"Sanghera, D. K., Sapkota, B. R., Aston, C. E. & Blackett, P. R. Vitamin D status, gender differences, and cardiometabolic health disparities. Ann. Nutr. Metab. 70(2), 79\u201387. https:\/\/doi.org\/10.1159\/000458765 (2017).","journal-title":"Ann. Nutr. Metab."},{"issue":"3","key":"24053_CR28","doi-asserted-by":"publisher","first-page":"14117","DOI":"10.1001\/jamanetworkopen.2021.4117","volume":"4","author":"DO Meltzer","year":"2021","unstructured":"Meltzer, D. O., Best, T. J. & Vokes, Z. H. Association of vitamin D levels, race\/ethnicity, and clinical characteristics with COVID-19 test results. JAMA Netw. Open. 4(3), 14117. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.4117 (2021).","journal-title":"JAMA Netw. Open."},{"key":"24053_CR29","unstructured":"Richie, H., Ortiz-Ospina, E., Beltekian, D., Mathieu, E., Hassel, J., Macdonald, B., Giattino, C., Appel, C., & Roser, M. Statistics and research\u2014Coronavirus pandemic (COVID-19). Our World in Data. Accessed March 21, 2021. Available at https:\/\/ourworldindata.org\/coronavirus."},{"key":"24053_CR30","unstructured":"United States Department of Veterans Affairs. COVID-19 National Summary. Accessed October 3, 2021. Available at https:\/\/www.accesstocare.va.gov\/Healthcare\/COVID19NationalSummary."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24053-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24053-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24053-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T22:41:13Z","timestamp":1678574473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24053-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24053"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24053-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. DO Meltzer reported grants from the National Institutes of Health during the conduct of the study. Dr. JB Gibbons, Dr. J Lavigne, Dr. VC Fiedler, Dr. EC Norton, Dr. J McCullough, Dr. RD Gibbons have no conflicts to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19397"}}